A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a prospective, randomized, multi-center, active-controlled, double-blind, double-dummy, multicenter, non-inferiority study comparing the clinical efficacy, safety and tolerability of ProF-001 to fluconazole.
Epistemonikos ID: 56a6a0864793a063e79b9c0672bbbed68541d42f
First added on: May 08, 2024